Call for Abstracts

ABSTRACT SUBMISSION IS NOW CLOSED

​​

​Abstract submission deadline: Wednesday, January 8, 2014

Abstract submission deadline extended to: Saturday, ​January 18, 2014

Thank you to all the participants who submitted abstracts.

​Abstracts will now be reviewed and assigned to appropriate sessions.

Abstracts will be selected for Poster Presentation, and a limited number of abstracts will be scheduled for oral presentation. Authors will be notified of acceptance and the format of presentation by February 14​, 2014.

EAS EMBARGO POLICY

The findings described in​ an abstract accepted for presentation at EAS Congress may not be published, presented elsewhere, or otherwise publicly discussed prior to their presentation at the EAS Congress.

​GUIDELINES FOR SUBMISSION

  1. The abstract should be as informative as possible:
    • Aim: state background and specific objective of study
    • Methods: shortly describe methods used
    • Results: summarize results obtained​
    • Conclusions: state conclusions reached​
  1. Standard abbreviations may be used.
  2. Inclusion in the Scientific Program and Congress publications is dependent upon payment of registration fees.
  3. Abstracts should be submitted in good English, in order to facilitate fair scientific evaluation.
  4. Abstract length should not exceed 300 words.
​​
Workshop/Oral Presentation Topics
1 - Metabolism and functions of lipids in vascular cells
2 - Immunology of atherosclerosis
3 - Atherosclerosis regression
4 - Endothelial cell biology and angiogenesis
5 - Genomics and proteomics of lipid metabolism
6 - New protective effects of HDL on the cardiovascular system and beyond
7 - Role of the intestine for lipid homeostasis and atherosclerosis
8 - Adipose tissue biology
9 - Hypolidaemic drugs present and future
10 - nutrition and nutraceuticals
11 - Gene-environment interactions and Epigenetics
12 - Environmental and psychosocial stressors in cardiovascular disease

 

Poster Topics

13 - Endothelial cells and function
14 - Smooth muscle cells
15 - Macrophages
16 - Epigenetics and microRNA
17 - Gene expression
18 - Extracellular matrix and calcification
19 - Inflammation
20 - Coagulation and Thrombosis
21 - Innate immunity
22 - Adaptive immunity
23 - Infection and atherosclerosis
24 - Hormones and atherosclerosis
25 - Vascular biology of the arterial wall: Miscellaneous
26 - Native  and modified LDL
27 - Lp(a)
28 - TG rich and post prandial lipoproteins
29 - HDL structure and function
30 - HDL metabolism
31 - Lipoprotein receptors
32 - Lipases and lipid transfer proteins
33 - Cholesterol efflux and reverse cholesterol transport
34 - Intestinal and biliary lipid metabolism
35 - Lipids beyond cholesterol and triglycerides (lipidomics)
36 - Cellular lipid metabolism
37 - Diabetes, insulin sensitivity and resistance
38 - Obesity and adipose tissue
39 - Microbiota
40 - Inherited  dyslipidemias
41 - Secondary dyslipidaemia
42 - Polygenetic and multifactorial dyslipidemias 
43 - Lipid and lipoprotein metabolism: Miscellaneous
44 - Gender and cardiovascular risk
45 - Epidemiology  of dyslipidemias
46 - Epidemiology  of cardiovascular disesases and hypertension
47 - Epidemiology  of overweight and obesity and related diseases
48 - Epidemiology  of smoking and other behavioural risk factors
49 - Epidemiology  of pollution and other environmental  risk factors
50 - Epidemiology  of socioeconomic and psychosocial  risk factors
51 - Novel risk factors and biomarkers
52 - GWAS, population genetics, Mendelian randomization
53 - Endothelial dysfunction clinical assessment
54 - Imaging of coronary arteries or the heart
55 - Intima media thickness and other imaging of peripheral arteries
56 - Obesity and fat distribution
57 - Diabetes and metabolic syndrome
58 - NASH and related disorders
59 - Sub inflammatory states
60 - Chronic kidney disease and nephropathies
61 - Diabetic  macro- and microangiopathies
62 - Aneurysms and other non-atherosclerotic  arteriopathies
63 - Cessation of active and passive smoking
64 - Intervention into physical activity
65 - Dietary and bariatric interventions
66 - Lipid-lowering therapy
67 - Blood pressure lowering therapies
68 - Antithrombotic therapies
69 - Anti-infammatory  therapies
70 - Intravascular procedures
71 - Risk factors, epidemiology, prevention and treatment of cardiovascular diseases: Miscellaneous

Keep Me Updated